Stockchase Opinions

Jonathen Wellum, B. Comm, B. Sc Hartford Financial HIG-N TOP PICK Oct 10, 2006

Has both property and casualty as well as life insurance, but trades off P&C mainly. Trades at 10-11 X earnings. Big in wealth management. Diversified into the far east and Japan.
$88.790

Stock price when the opinion was issued

insurance
It's the ideal tool to help you make quicker, more informed decisions for managing and tracking your investments.

You might be interested:

TOP PICK
Life insurance, diverse. Inexpensive. Has been taken down because of hurricanes.
HOLD
Subject to rumours today that Sun Life (SLF-T) is going to take a run at it subject to takeover rumours last week of another purchaser. If you own, Hold to see how it plays out.
WEAK BUY
Looks good. Would like to see it get above $21. Insurance companies need stocks and interest rates to go up. Buy on a dip and then unload at resistance. Not a long-term investment.
COMMENT

Chubb's failed to take over HIG-N. HIG kept rejecting Chubb's bids, even though HIB shares jumped after the initial news. Last Thursday, HIG rejected yet another bid as HIG reported an okay, though imperfect quarter. Though Chubb has backed down, HIG shares aren't sliding, but rallying since the takeover died. Shares are up 76% in the last 6 months.

premium

This is a Panic-proof Portfolio opinion which is available only for Premium members

Curated by Michael O'Reilly since 2020.
1550+ opinions with 4.81 rating (one of the best performing expert).

TOP PICK
Stockchase Research Editor: Michael O'Reilly This $20 billion market cap provider of multi-line insurance including group disability and casualty insurance is a TOP PICK. The company is partnering with Yale Medical to develop training in addiction and pain management to help provide reduce opioid use disorders. It trades at 11x earnings and 1.2x book value. We like how it has managed its cash reserves while buying back stock aggressively and retiring debt. Its dividend has grown by over 8% annually over the past five years and is backed by a payout ratio under 30% of cash flow. We recommend placing a stop loss at $52.50, looking to achieve $82.50 -- upside potential over 30%. Yield 2.49% (Analysts’ price target is $82.35)
premium

This is a Panic-proof Portfolio opinion which is available only for Premium members

Curated by Michael O'Reilly since 2020.
1550+ opinions with 4.81 rating (one of the best performing expert).

PAST TOP PICK
(A Top Pick Sep 29/22, Up 17.8%)Stockchase Research Editor: Michael O'Reilly Our PAST TOP PICK with HIG is progressing well. To remain disciplined, we now recommend trailing up the stop (from $52.50) to $60.50.
premium

This is a Panic-proof Portfolio opinion which is available only for Premium members

Curated by Michael O'Reilly since 2020.
1550+ opinions with 4.81 rating (one of the best performing expert).

TOP PICK
Stockchase Research Editor: Michael O'Reilly We reiterate this $20 billion market cap provider of multi-line insurance including group disability and casualty insurance as a TOP PICK. The company is embarking on a major cost saving initiative and reports lower losses related to COVID and commercial lines. It trades at 13x earnings and 1.9x book value. We like how it has managed its cash reserves while buying back stock aggressively and retiring debt. Its dividend has grown by over 8% annually over the past five years and is backed by a payout ratio under 30% of cash flow. We recommend trailing up the stop loss from ($60.50) to $68.50, looking to achieve $85.50 -- upside potential over 14%. Yield 2.3% (Analysts’ price target is $85.44)
premium

This is a Panic-proof Portfolio opinion which is available only for Premium members

Curated by Michael O'Reilly since 2020.
1550+ opinions with 4.81 rating (one of the best performing expert).

PAST TOP PICK
(A Top Pick Dec 20/22, Down 8.6%)Stockchase Research Editor: Michael O’Reilly

Our PAST TOP PICK with HIG has triggered its stop at $68.50.  To remain disciplined, we recommend covering the position at this time.  When combined with our previous buy recommendation, this will result in a net investment gain of 0.3%.